{
    "2020-03-24": [
        [
            {
                "time": "2020-03-24",
                "original_text": "达成全年物业合同销售目标 中国奥园年度净利大增78%至52.2亿元",
                "features": {
                    "keywords": [
                        "中国奥园",
                        "物业合同",
                        "净利",
                        "增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "房地产"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-26",
                "original_text": "药明康德发布《未来三年(2020年-2022年)股东回报规划》",
                "features": {
                    "keywords": [
                        "药明康德",
                        "股东回报",
                        "规划"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-26",
                "original_text": "药明康德2019成绩单：营收128.72亿元，60%收入来自美国客户",
                "features": {
                    "keywords": [
                        "药明康德",
                        "营收",
                        "美国客户"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-03-26",
                "original_text": "药明康德2019年度净利润下降17.96%至18.55亿元拟10转4派3.37元 盈利能力下降",
                "features": {
                    "keywords": [
                        "药明康德",
                        "净利润",
                        "下降",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-03-26",
                "original_text": "北向资金今日净流入39.87亿元，药明康德再获净买入3.16亿元",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净流入",
                        "药明康德"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}